MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-12-31, ISPR had -$5,093,784 decrease in cash & cash equivalents over the period. -$4,036,160 in free cash flow.

Cash Flow Overview

Change in Cash
-$5,093,784
Free Cash flow
-$4,036,160
Unit: Dollar
Positive Cash Flow Breakdown
    • Credit loss expenses
    • Accounts receivable
    • Contract liabilities
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Accounts payable and accounts pa...
    • Prepaid expenses and other curre...
    • Others

Cash Flow
2025-12-31
2025-09-30
2025-06-30
Net loss
-6,602,911 -3,258,863 -39,240,226
Depreciation and amortization
227,832 253,410 812,483
Credit loss expenses
4,209,201 1,764,252 22,034,812
Right-of-use assets amortization
384,396 307,740 1,460,104
Stock-based compensation expenses
821,841 938,148 5,616,282
Inventory impairment
1,113,981 423,457 754,976
Loss from equity method investment
-187,054 -199,279 -732,502
Right-of-use assets impairment
--151,516
Debt issuance cost amortization
32,313 32,312 38,478
Accounts receivable
-2,435,242 -744,255 9,331,350
Inventories
-10,723 -62,395 1,037,552
Prepaid expenses and other current assets
1,478,342 -509,535 547,085
Accounts payable and accounts payable related party
-6,514,178 -496,695 10,766,537
Contract liabilities
2,008,836 -1,898,951 2,643,084
Accrued liabilities and other payables
-201,093 -576,181 -555,383
Operating lease liabilities
-332,413 -469,556 -1,358,074
Income tax payable
-269,266 281,856 -315,189
Net cash (used in)/provided by operating activities
-3,966,784 -1,183,607 -7,374,085
Purchase of property, plant and equipment
69,376 7,502 1,100,704
Capitalized costs for patents
160,308 132,534 939,075
Repayment of acquisition payable
--3,158,826
Investment in joint venture
533,311 --
Net cash used in investing activities
-762,995 -140,036 -5,198,605
Common stock repurchase
45,001 -60,488
Proceeds from borrowing
--2,080,863
Repayment of borrowing
319,004 319,004 167,214
Net cash used in financing activities
-364,005 -319,004 1,853,161
Net decrease in cash
-5,093,784 -1,642,647 -10,719,529
Cash and cash equivalents at beginning of period
22,709,118 24,351,765 -
Cash and cash equivalents at end of period
17,615,334 22,709,118 -
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net decrease in cash-$5,093,784 Credit loss expenses$4,209,201 Accounts receivable-$2,435,242 Contract liabilities$2,008,836 Inventory impairment$1,113,981 Stock-based compensationexpenses$821,841 Right-of-use assetsamortization$384,396 Depreciation andamortization$227,832 Loss from equitymethod investment-$187,054 Debt issuance costamortization$32,313 Inventories-$10,723 Net cash (usedin)/provided by operating...-$3,966,784 Net cash used ininvesting activities-$762,995 Net cash used infinancing activities-$364,005 Canceled cashflow$11,431,419 Net loss-$6,602,911 Investment in joint venture$533,311 Capitalized costs forpatents$160,308 Purchase of property,plant and equipment$69,376 Repayment of borrowing$319,004 Common stockrepurchase$45,001 Accounts payable andaccounts payable related...-$6,514,178 Prepaid expenses andother current assets$1,478,342 Operating leaseliabilities-$332,413 Income tax payable-$269,266 Accrued liabilities andother payables-$201,093

Ispire Technology Inc. (ISPR)

Ispire Technology Inc. (ISPR)